This study established radiomic prediction models for CD3+ T, CD8+ T, and CD8+ TRM immune cell infiltration levels, and then predicted the level of immune cell infiltration in tumor tissues of NSCLC patients in the immunotherapy cohort based on the radiomic model of the TIME. This evidence concerns the gene CD8A and non-small cell lung carcinoma.